CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Celgene Corp  (CELG)
Other Ticker:  
 


 

Celgene Corp

CELG's Financial Statements and Analysis





Celgene Corp reported in III. Quarter net earnings per share of $1.50 an increase by 23.97 % year on year from $1.21 and an improvement of 4.9 % from $1.43 realized in II. Quarter (Jun 30 2018).

Celgene's Revenue rose by % in III. Quarter (Sep 30 2018) year on year, to $3,892 million and advanced by 2.05 % sequentially.


Celgene is Expected to report next financial results on January 22, 2019.

More on CELG's Income Statement
III. Quarter
Earnings Per Share Revenues
$ 1.5 $  3,892 Mill
$+0.29     +23.97 % $+605M     +18.41 %


       
  • REVLIMID 11.81% Y/Y,
• ABRAXANE 8.34% Y/Y,
• Other 350% Y/Y,
• Total product sales 18.18% Y/Y,
• ISTODAX 10.19% Y/Y,
• POMALYST, IMNOVID 41.63% Y/Y,
• azacitidine injection 7.04% Y/Y
   
     
       
  • THALOMID -13.1% Y/Y,
• VIDAZA -6.46% Y/Y
   
     


CELG's Segments

Celgene's net income of $1,082 million in III. Quarter increased by 9.51 % from net earnings of $988 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 3.54 % from net income of $1,045.00 million realized in previous quarter.

More on CELG's Growth

Inventories Inventories declined by -5.03 % to $510.00 million from III. Quarter a year ago, sequentially inventories fell by -8.11 %. CELG's Cash flow In III. Quarter company's net cash flow was $977 million, capital expenditures fell by 45.45%, to $-64 millions compare to same quarter a year ago and rose by -20.00% from II. Quarter (Jun 30 2018).

More on CELG's Cash flow Statement


Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 6.28 cash per share, on a free-cash flow basis 159.7 % of net earning per share.

Book value grew by 44.23 % sequentially to $6.75 per share, -135.63% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -27.08 per share from $ -28.73.

Company repurchased 12.90 million shares or 1.76 % in III. Quarter.
Interest Coverage Ratio was 6.24. Debt Coverage Ratio was 0.3.

More on CELG's Dividends
 Market Capitalization (Millions) 49,084
 Shares Outstanding (Millions) 720
 Total Debt (Millions $) 20,244
 Revenue (TTM) (Millions $) 14,727
 Net Income (TTM) (Millions $) -17
 Cash Flow (TTM) (Millions $) -3,031
 Capital Exp. (TTM) (Millions $) -335
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012




Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 6.28 cash per share, on a free-cash flow basis 159.7 % of net earning per share.

Book value grew by 44.23 % sequentially to $6.75 per share, -135.63% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -27.08 per share from $ -28.73.

Company repurchased 12.90 million shares or 1.76 % in III. Quarter.
Interest Coverage Ratio was 6.24. Debt Coverage Ratio was 0.3.

More on CELG's Dividends
 Market Capitalization (Millions) 49,084
 Shares Outstanding (Millions) 720
 Total Debt (Millions $) 20,244
 Revenue (TTM) (Millions $) 14,727
 Net Income (TTM) (Millions $) -17
 Cash Flow (TTM) (Millions $) -3,031
 Capital Exp. (TTM) (Millions $) -335
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012


   

     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CBAI's Profile

Stock Price

CBAI's Financials

Business Description

Fundamentals

Charts & Quotes

CBAI's News

Suppliers

CBAI's Competitors

Customers & Markets

Economic Indicators

CBAI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071